Eurofins MWG Operon LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Eurofins MWG Operon LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10887
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Eurofins MWG Operon LLC (Eurofins) is a DNA sequencing service provider. The company offers DNA sequencing services, DNA synthesis products, and bioinformatic services. Its product categories comprise DNA and RNA synthesis, DNA sequencing, GENE synthesis and next gen seq. Eurofins provides next gen DNA technology express oligos, extremer oligos, custom DNA oligos, custom RNA/chimeric oligos, NGS application oligos, QPCR / MGB probes, crisprs products, simax sirna, purification and yields and modifications. The company also offers sequencing dashboard, overnight sequencing, simpleseq kits, flexreads, tube sequencing, plate sequencing, fragment analysis, plasmid verification, clinical and GLP services and standard primers. The company has its presence in the US, India, Europe and Japan. Eurofins is headquartered in Louisville, Kentucky, the US.

Eurofins MWG Operon LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Eurofins MWG Operon LLC, Medical Devices Deals, 2012 to YTD 2018 9
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Rubicon Genomics Enters into Distribution Agreeement with Eurofins MWG Operon 11
Eurofins MWG Operon And Floragenex Enter Into Co-Marketing Agreement For RAD Sequencing Services 12
Acquisition 13
Eurofins MWG Operon Acquires Entelechon, Gene Synthesis Provider 13
Eurofins MWG Operon LLC – Key Competitors 14
Eurofins MWG Operon LLC – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Other Significant Developments 16
Mar 14, 2017: Eurofins Genomics US Announces Commercial Launch of Next Generation DNA Synthesis Service 16
Jan 16, 2017: Eurofins Genomics Expands Express Oligo Service 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Key Facts 2
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eurofins MWG Operon LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Eurofins MWG Operon LLC, Medical Devices Deals, 2012 to YTD 2018 9
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Rubicon Genomics Enters into Distribution Agreeement with Eurofins MWG Operon 11
Eurofins MWG Operon And Floragenex Enter Into Co-Marketing Agreement For RAD Sequencing Services 12
Eurofins MWG Operon Acquires Entelechon, Gene Synthesis Provider 13
Eurofins MWG Operon LLC, Key Competitors 14
Eurofins MWG Operon LLC, Other Locations 15
Eurofins MWG Operon LLC, Subsidiaries 15

List of Figures
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Eurofins MWG Operon LLC, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Eurofins MWG Operon LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Genesis Care Pty Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Genesis Care Pty Ltd (Genesis Care) is a healthcare service provider. The company provides radiation oncology, cardiology and sleep treatment services. It offers radiotherapy, intensity modulated radiotherapy, volumetric arc therapy, stereotactic radiotherapy and radiosurgery, low dose rate …
  • American Air Filter Co Inc:企業の戦略的SWOT分析
    American Air Filter Co Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Enlight Renewable Energy Ltd (ENLT):企業の財務・戦略的SWOT分析
    Summary Enlight Renewable Energy Ltd (Enlight Renewable) is a renewable energy company that invests, develops, finances, constructs, operates and manages electricity production projects from renewable energy sources. The company develops photovoltaic technology by which solar energy is converted to …
  • Macquarie Infrastructure Corporation:企業のM&A・事業提携・投資動向
    Macquarie Infrastructure Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Macquarie Infrastructure Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • Acura Pharmaceuticals Inc (ACUR)-医療機器分野:企業M&A・提携分析
    Summary Acura Pharmaceuticals Inc (Acura) is a specialty pharmaceutical company that researches, develops, and commercializes tamper-resistant products to prevent the abuse and misuse of medication. The company’s proprietary technologies, Aversion, Limitx and Impede, are used to prevent product tamp …
  • CIMIC Group Ltd (CIM):企業の財務・戦略的SWOT分析
    CIMIC Group Ltd (CIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • First Hotel Company Ltd.:企業の戦略・SWOT・財務情報
    First Hotel Company Ltd. - Strategy, SWOT and Corporate Finance Report Summary First Hotel Company Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Elizabeth Arden, Inc.:企業の戦略的SWOT分析
    Elizabeth Arden, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • American Electric Power Company, Inc. (AEP)-エネルギー分野:企業M&A・提携分析
    Summary American Electric Power Company, Inc. (AEP) is a holding company that carries out the generation, transmission and distribution of electricity through its subsidiaries. The company generates electricity through various sources of energy such as coal and lignite, natural gas, nuclear, and hyd …
  • Panther Energy Company LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Panther Energy Company LLC (PEC) is an oil and gas company that offers drilling services. The company’s business activities include exploration, acquisition, development and production of oil, natural gas liquids and natural gas. It carries out grassroots horizontal exploration of unconventi …
  • Travelzoo Inc.:企業の戦略・SWOT・財務情報
    Travelzoo Inc. - Strategy, SWOT and Corporate Finance Report Summary Travelzoo Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Wockhardt Ltd (WOCKPHARMA):製薬・医療:M&Aディール及び事業提携情報
    Summary Wockhardt Ltd (Wockhardt) is a pharmaceutical company that manufactures and markets vaccines, active pharmaceutical ingredients, pharmaceutical and recombinant bio-pharmaceutical formulations. The company's product portfolio caters to various therapeutic areas including orthopedics, dental c …
  • Western Area Power Administration:企業の戦略的SWOT分析
    Western Area Power Administration - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Neurosigma Inc:企業の製品パイプライン分析2018
    Summary Neurosigma Inc (Neurosigma) is a life science company that develops and commercializes trigeminal nerve stimulation technologies for neurologic and psychiatric disorders. The company offers treatments for epilepsy, depression, attention deficit hyperactivity disorder, and post-traumatic stre …
  • Yum China Holdings Inc (YUMC):企業の財務・戦略的SWOT分析
    Yum China Holdings Inc (YUMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Engie SA (ENGI):電力:M&Aディール及び事業提携情報
    Summary Engie SA (Engie) is an electric utility. It provides electricity, natural gas, and energy services. It generates electricity from hydro, wind, biomass, and solar sources, and trades and sells that energy; supplies, distributes, trades, and sells natural gas; and offers a comprehensive range …
  • FHI 360:企業の戦略的SWOT分析
    FHI 360 - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Wilmar International Ltd (F34):企業の財務・戦略的SWOT分析
    Wilmar International Ltd (F34) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Clean TeQ Holdings Ltd (CLQ):企業の財務・戦略的SWOT分析
    Summary Clean TeQ Holdings Ltd (Clean TeQ) is a clean technology company that offers air pollution control solutions using biotechnology-based processes. The company provides water treatment products such as advanced separations, advanced oxidation, encapsulated bacteria, continuous ionic filtration …
  • Uni-President Enterprises Corp:戦略・SWOT・企業財務分析
    Uni-President Enterprises Corp - Strategy, SWOT and Corporate Finance Report Summary Uni-President Enterprises Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆